SciELO - Scientific Electronic Library Online

vol.21 issue3Main causes related to the orthodontics treatment cessation by school children and young adults according to types of braces usedValue of the digital vein for the traditional diagnosis and prognosis of diarrheas in an infant author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand




  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO



On-line version ISSN 1029-3019


CLAPE LAFFITA, Oneyda et al. Implementation of immunotherapeutical products in cancer clinical trials in Santiago de Cuba. MEDISAN [online]. 2017, vol.21, n.3, pp.313-319. ISSN 1029-3019.

A retrospective descriptive study on the presentation of clinical trials was carried out during 23 years in Santiago de Cuba, with the objective of describing the implementation of 3 immunotherapeutical products (CIMAher-Nimotuzumab, CIMAvax-EGF and Vaxira-Racotumomab) for the treatment of patients with cancer in hospitals and polyclinics from the province. The final reports of each clinical trial and the available information of the promoter center were reviewed from 1992 to 2015. Twenty protocols of clinical trials were implemented by 500 investigators of 25 specialties distributed in 4 hospitals of the province and 4 primary health care areas, where 2 clinical trials in patients with lung cancer were carried out. It was concluded that the implementation of these immunotherapeutical products contributed to the health registration of them, enriching the therapeutic arsenal for the treatment of patients with cancer in Santiago de Cuba, with a high social impact

Keywords : immunotherapeutical products; CIMAher-Nimotuzumab; CIMAvax-EGF and Vaxira-Racotumomab; clinical trial.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )


Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License